Free fatty acid profiles in preeclampsia

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 81, Issue 1, 2009, Pages 17-21

  Villa, Pia M ^a,b   Laivuori, Hannele ^a,c   Kajantie, Eero ^d,e   Kaaja, Risto ^f  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^e HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^f UNIVERSITY OF TURKU   (Finland)

Author keywords

Arachidonic acid; Free fatty acid; Hypertension; Insulin sensitivity; Linoleic acid; Lipids; Metabolic syndrome; Metabolism; Preeclampsia; Pregnancy

Indexed keywords

ARACHIDONIC ACID; FATTY ACID; LINOLEIC ACID; OLEIC ACID;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FATTY ACID ANALYSIS; FATTY ACID BLOOD LEVEL; FEMALE; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; ORAL GLUCOSE TOLERANCE TEST; PREECLAMPSIA; PREGNANT WOMAN; PRIORITY JOURNAL;

ARACHIDONIC ACID; FATTY ACIDS, NONESTERIFIED; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN RESISTANCE; LINOLEIC ACID; OLEIC ACID; PRE-ECLAMPSIA; PREGNANCY;

EID: 67649435981     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2009.05.002     Document Type: Article

References (39)

1. Smith C.G., Pell J.P., and Walsh D. Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129,290 births. Lancet 357 (2001) 2002-2006
2. Haukkamaa L., Salminen M., Laivuori H., Leinonen H., Hiilesmaa V., and Kaaja R. Risk for subsequent coronary artery disease after preeclampsia. Am. J. Cardiol. 93 (2004) 805-808
3. Pell J.P., Smith G.C., and Walsh D. Pregnancy complications and subsequent maternal cerebrovascular events: a retrospective cohort study of 119,668 births. Am. J. Epidemiol. 159 (2004) 336-342
4. Leik C.E., and Walsh S.W. Linoleic acid, but not oleic acid, upregulates production of interleukin-8 by human vascular smooth muscle cells via arachidonic acid metabolites under conditions of oxidative stress. J. Soc. Gynecol. Investig. 12 (2005) 593-598
5. Rodie V.A., Freeman D.J., Sattar N., and Greer I.A. Pre-eclampsia and cardiovascular disease: metabolic syndrome of pregnancy?. Atherosclerosis 175 (2004) 189-202
6. Bellamy L., Casas J.P., Hingorani A.D., and Williams D.J. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ 335 (2007) 974
7. Libby G., Murphy D.J., McEwan N.F., et al. Pre-eclampsia and the later development of type 2 diabetes in mothers and their children: an intergenerational study from the walker cohort. Diabetologia 50 (2007) 523-530
8. Vatten L.J., Romundstad P.R., Holmen T.L., Hsieh C.C., Trichopoulos D., and Stuver S.O. Intrauterine exposure to preeclampsia and adolescent blood pressure, body size, and age at menarche in female offspring. Obstet. Gynecol. 101 (2003) 529-533
9. Tenhola S., Rahiala E., Halonen P., Vanninen E., and Voutilainen R. Maternal preeclampsia predicts elevated blood pressure in 12-year-old children: evaluation by ambulatory blood pressure monitoring. Pediatr. Res. 59 (2006) 320-324
10. Kaaja R., Tikkanen M.J., Viinikka L., and Ylikorkala O. Serum lipoproteins, insulin, and urinary prostanoid metabolites in normal and hypertensive pregnant women. Obstet. Gynecol. 85 (1995) 353-356
11. Kaaja R., Laivuori H., Laakso M., Tikkanen M.J., and Ylikorkala O. Evidence of a state of increased insulin resistance in preeclampsia. Metabolism 48 (1999) 892-896
12. Laivuori H., Tikkanen M.J., and Ylikorkala O. Hyperinsulinemia 17 years after preeclamptic first pregnancy. J. Clin. Endocrinol. Metab. 81 (1996) 2908-2911
13. Garovic V.D., and Hayman S.R. Hypertension in pregnancy: an emerging risk factor for cardiovascular disease. Nat. Clin. Pract. Nephrol. 3 (2007) 613-622
14. Magnussen E.B., Vatten L.J., Lund-Nilsen T.I., Salvesen K.A., Davey Smith G., and Romundstad P.R. Prepregnancy cardiovascular risk factors as predictors of pre-eclampsia: population based cohort study. BMJ 335 (2007) 978
15. Manten G.T., Sikkema M.J., Voorbij H.A., Visser G.H., Bruinse H.W., and Franx A. Risk factors for cardiovascular disease in women with a history of pregnancy complicated by preeclampsia or intrauterine growth restriction. Hypertens. Pregnancy 26 (2007) 39-50
16. Herrera E. Metabolic adaptations in pregnancy and their implications for the availability of substrates to the fetus. Eur. J. Clin. Nutr. 54 (2000) S47-S51
17. Lorentzen B., Endresen M.J., Clausen T., and Henriksen T. Fasting serum free fatty acids and triglycerides are increased before 20 weeks of gestation in women who later develop preeclampsia. Hypertens. Pregnancy 13 (1994) 103-109
18. Lorentzen B., Drevon C.A., Endresen M.J., and Henriksen T. Fatty acid pattern of esterified and free fatty acids in sera of women with normal and pre-eclamptic pregnancy. Br. J. Obstet. Gynaecol. 102 (1995) 530-537
19. Hubel C.A., McLaughlin M.K., Evans R.W., Hauth B.A., Sims C.J., and Roberts J.M. Fasting serum triglycerides, free fatty acids, and malondialdehyde are increased in preeclampsia, are positively correlated, and decrease within 48 hours post partum. Am. J. Obstet. Gynecol. 174 (1996) 975-982
20. Murai J.T., Muzykanskiy E., and Taylor R.N. Maternal and fetal modulators of lipid metabolism correlate with the development of preeclampsia. Metabolism 46 (1997) 963-967
21. Potter J.M., and Nestel P.J. The hyperlipidemia of pregnancy in normal and complicated pregnancies. Am. J. Obstet. Gynecol. 133 (1979) 165-170
22. Herrera E., Lasuncion M.A., Gomez-Coronado D., Aranda P., Lopez-Luna P., and Maier I. Role of lipoprotein lipase activity on lipoprotein metabolism and the fate of circulating triglycerides in pregnancy. Am. J. Obstet. Gynecol. 158 (1988) 1575-1583
23. Biezenski J.J. Maternal lipid metabolism. Obstet. Gynecol. Annu. 3 (1974) 203-233
24. Alvino G., Cozzi V., Radaelli T., Ortega H., Herrera E., and Cetin I. Maternal and fetal fatty acid profile in normal and intrauterine growth restriction pregnancies with and without preeclampsia. Pediatr. Res. 64 (2008) 615-620
25. Cetin I., Giovannini N., Alvino G., Agostoni C., Riva E., Giovannini M., and Pardi G. Intrauterine growth restriction is associated with changes in polyunsaturated fatty acid fetal-maternal relationships. Pediatr. Res. 52 (2002) 750-755
26. Schobel H.P., Fischer T., Heuszer K., Geiger H., and Schmieder R.E. Preeclampsia-a state of sympathetic overactivity. N. Engl. J. Med. 335 (1996) 1480-1485
27. Fasshauer M., Seeger J., Waldeyer T., Schrey S., Ebert T., Kratzsh J., et al. Serum levels of the adipokine adipocyte fatty-acid-binding protein are increased in preeclampsia. Am. J. Hypertens. 21 (2008) 582-586
28. Kajantie E., Kaaja R., Ylikorkala O., Andersson S., and Laivuori H. Adiponectin concentrations in maternal serum: elevated in preeclampsia but unrelated to insulin sensitivity. J. Soc. Gynecol. Investig. 12 (2005) 433-439
29. Xu A., Tso A.W.K., Cheung B.M.Y., Wang Y., Wat N.M.S., Fong C.H.Y., et al. Circulating adipocyte fatty acid-binding protein levels predict the development of metabolic syndrome: a 5-year prospective study. Circulation 115 (2007) 1537-1543
30. Endresen M.J., Lorentzen B., and Henriksen T. Increased lipolytic activity and high ratio of free fatty acids to albumin in sera from women with preeclampsia leads to triglyceride accumulation in cultured endothelial cells. Am. J. Obstet. Gynecol. 167 (1992) 440-447
31. Sattar N., Gaw A., Packard C.J., and Greer I.A. Potential pathogenic roles of aberrant lipoprotein and fatty acid metabolism in pre-eclampsia. Br. J. Obstet. Gynaecol. 103 (1996) 614-620
32. Szczeklik A., Gryglewski R.J., Nizankowski R., Musial J., Pieton R., and Mruk J. Circulatory and anti-platelet effects of intravenous prostacyclin in healthy men. Pharmacol. Res. Commun. 10 (1978) 545-556
33. Granstrom E., Diczfalusy U., Hamberg M., Hansson G., Malmsten C., and Samuelsson B. Thromboxane a2: biosynthesis and effects on platelets. Adv. Prostaglandin Thromboxane Leukot. Res. 10 (1982) 15-58
34. Endresen M.J., Tosti E., Heimli H., Lorentzen B., and Henriksen T. Effects of free fatty acids found increased in women who develop pre-eclampsia on the ability of endothelial cells to produce prostacyclin, cGMP and inhibit platelet aggregation. Scand. J. Clin. Lab. Invest. 54 (1994) 549-557
35. Lorentzen B., Endresen M.J., Hovig T., Haug E., and Henriksen T. Sera from preeclamptic women increase the content of triglycerides and reduce the release of prostacyclin in cultured endothelial cells. Thromb. Res. 63 (1991) 363-372
36. Friedman S.A. Preeclampsia: a review of the role of prostaglandins. Obstet. Gynecol. 71 (1988) 122-137
37. Saeed S.A., and Mitchell M.D. Lipoxygenase activity in human uterine and intrauterine tissues: new prospects for control of prostacyclin production in pre-eclampsia. Clin. Exp. Hypertens. B 2 (1983) 103-111
38. Ogburn Jr. P.L., Williams P.P., Johnson S.B., and Holman R.T. Serum arachidonic acid levels in normal and preeclamptic pregnancies. Am. J. Obstet. Gynecol. 148 (1984) 5-9
39. Leik C.E., and Walsh S.W. Neutrophils infiltrate resistance-sized vessels of subcutaneous fat in women with preeclampsia. Hypertension 44 (2004) 72-77